Cyclic nucleotide signaling mechanisms in trypanosomes: Possible targets for therapeutic agents

Molecular Interventions

Volumn 7, Issue 4, 2007, Pages 203-215

  Laxman, Sunil ^a   Beavo, Joseph A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DICHLORO 1 BETA DEXTRO RIBOFURANOSYLBENZIMIDAZOLE 3',5' CYCLIC MONOPHOSPHOROTHIOATE; 8 (4 CHLOROPHENYLTHIO) 2' O METHYLADENOSINE 3',5' CYCLIC MONOPHOSPHATE; 8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; ADENYLATE CYCLASE; ADENYLATE CYCLASE ACTIVATOR; BENZIMIDAZOLE; CAFFEINE; CHOLERA TOXIN; CYCLIC AMP; CYCLIC AMP DERIVATIVE; DIPYRIDAMOLE; ETAZOLATE; ISOBUTYLMETHYLXANTHINE; METHYLXANTHINE DERIVATIVE; NIFURTIMOX; PENTAMIDINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PROTEIN KINASE; SURAMIN; THEOPHYLLINE; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; ANOREXIA; BETA SHEET; BONE MARROW DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; GENERALIZED EDEMA; HUMAN; LIFE CYCLE; NAUSEA; NONHUMAN; PROTEIN FUNCTION; RASH; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ADENYLATE CYCLASE; ANIMALS; CARRIER PROTEINS; CHAGAS DISEASE; CYCLIC AMP; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHOSPHORIC DIESTER HYDROLASES; PHYLOGENY; PROTEIN CONFORMATION; PROTOZOAN PROTEINS; RNA INTERFERENCE; SECOND MESSENGER SYSTEMS; TRYPANOCIDAL AGENTS; TRYPANOSOMA; TRYPANOSOMIASIS, AFRICAN;

EID: 34548728165     PISSN: 15340384     EISSN: 15432548     Source Type: Journal    
DOI: 10.1124/mi.7.4.7     Document Type: Review

References (83)

1. Molyneux, D.H., Hotez, P.J. and Fenwick, A. "Rapid-impact interventions": How a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med. 2, e336 (2005).
2. Cook, G. and Zumla, A. (2002) Manson's Tropical Diseases, 21st edition. Saunders Press
3. World Health Organization Control of Chagas Disease (2nd report of the WHO Expert Committee on Chagas Disease, Brasília, 20-28 November 2000), WHO Technical Report Series No. 905, Geneva, WHO (2002).
4. Matthews, K.R. The developmental cell biology of Trypanosoma brucei. J. Cell Sci. 118, 283-290 (2005).
5. Tyler, K.M. and Engman, D.M. The life cycle of Trypanosoma cruzi revisited. Int. J. Parasitol. 31, 472-481 (2001).
6. Nok, A.J. Effective measures for controlling trypanosomiasis. Expert Opin. Pharmacother. 6, 2645-2653 (2005).
7. Croft, S.L., Barrett, M.P., and Urbina, J.A. Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol. 21, 508-512 (2005).
8. Paulino, M., Iribarne, F., Dubin, M., Aguilera-Morales, S., Tapia, O., and Stoppani, A.O. The chemotherapy of Chagas disease: An overview. Mini Rev. Med. Chem. 5, 499-519 (2005).
9. Castro, J., de Mecca, M., and Bartel, L. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Hum. Exp. Toxicol. 25, 471-479 (2006).
10. Keiser, J., Stich, A., and Burri, C. New drugs for the treatment of human African trypanosomiasis: Research and development. Trends Parasitol. 17, 42-49 (2001).
11. Beavo, J.A. and Brunton, L.L. Cyclic nucleotide research - still expanding after half a century. Nat. Rev. Mol. Cell Biol. 3, 710-718 (2002). This review provides a broad overview of the current understanding of cAMP signaling and regulation in eukaryotes.
12. Bender, A.T. and Beavo, J.A. Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacol Rev. 58, 488-520 (2006).
13. Lugnier, C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents. Pharmacol. Ther. 109, 366-398 (2006).
14. Strickler, J.E. and Patton, C.L. Adenosine 3′,5′- monophosphate in reproducing and differentiated trypanosomes. Science 190, 1110-1112 (1975).
15. Mancini, P.E. and Patton, C.L. Cyclic 3′,5′-adenosine monophosphate levels during the developmental cycle of Trypanosoma brucei brucei in the rat. Mol. Biochem. Parasitol. 3, 19-31 (1981). References 14 and 15 were the earliest measurements of cAMP levels in trypanosomes during their different life cycle stages, showing clear oscillations of cAMP levels in these parasites during their developmental stages and suggesting the hypothesis that cAMP was important in trypanosome differentiation.
16. Rangel-Aldao, R., Triana, F., Fernandez, V., Comach, G., Abate, T., and Montoreano, R. Cyclic AMP as an inducer of the cell differentiation of Trypanosoma cruzi. Biochem. Int. 17, 337-344 (1988).
17. Rolin, S., Paindavoine, P., Hanocq-Quertier, J., Hanocq, F., Claes, Y., Le Ray, D., Overath, P., and Pays, E. Transient adenylate cyclase activation accompanies differentiation of Trypanosoma brucei from bloodstream to procyclic forms. Mol. Biochem. Parasitol. 61, 115-125 (1993).
18. Rolin, S., Hanocq-Quertier, J., Paturiaux-Hanocq, F., Nolan, D., Salmon, D., Webb, H., Carrington, M., Voorheis, P., and Pays, E. Simultaneous but independent activation of adenylate cyclase and glycosylphosphatidylinositol- phospholipase C under stress conditions in Trypanosoma brucei. J. Biol. Chem. 271, 10844-10852 (1996).
19. Gonzales-Perdomo, M., Romero, P., and Goldenberg, S. Cyclic AMP and adenylate cyclase activators stimulate Trypanosoma cruzi differentiation. Exp. Parasitol. 66, 205-212 (1988).
20. Reed, S.L., Fierer, A.S., Goddard, D.R., Colmerauer, M.E., and Davis, C.E. Effect of theophylline on differentiation of Trypanosoma brucei. Infect. Immun. 49, 844-847 (1985).
21. Bass, K.E. and Wang, C.C. The in vitro differentiation of pleomorphic Trypanosoma brucei from bloodstream into procyclic form requires neither intermediary nor short-stumpy stage. Mol. Biochem. Parasitol. 44, 261-270 (1991).
22. Vassella, E., Reuner, B., Yutzy, B., and Boshart, M. Differentiation of African trypanosomes is controlled by a density sensing mechanism which signals cell cycle arrest via the cAMP pathway. J. Cell Sci. 110, 2661-2671 (1997). This reference characterized the "Stumpy Inducing Factor" (SIF), which transforms slender, bloodstream forms of T. brucei to stumpy, non-proliferating forms and used cAMP analogs which appeared to mimic the effect of SIF, and suggested that the functional mechanism of SIF action was cAMP mediated.
23. Breidbach, T., Ngazoa, E., and Steverding, D. Trypanosoma brucei: In vitro slender-to-stumpy differentiation of culture-adapted, monomorphic bloodstream forms. Exp. Parasitol. 101, 223-230 (2002).
24. Santos, D.O. and Oliveira, M.M. Effect of cAMP on macromolecule synthesis in the pathogenic protozoa Trypanosoma cruzi. Mem. Inst. Oswaldo. Cruz. 83, 287-292 (1988).
25. Seebeck, T., Schaub, R., and Johner, A. cAMP signalling in the kinetoplastid protozoa. Curr. Mol. Med. 4, 585-599 (2004). This is a fairly recent review of cAMP signaling in all kinetoplastid protozoa, and gives a comprehensive overview of the early history of cAMP signaling in trypanosomes.
26. Seebeck, T., Gong, K., Kunz, S., Schaub, R., Shalaby, T., and Zoraghi, R. cAMP signalling in Trypanosoma brucei. Int. J. Parasitol. 31, 491-498 (2001).
27. Zingales, B., Carniol, C., Abramhamsohn, P.A., and Colli, W. Purification of an adenylyl cyclase-containing plasma membrane fraction from Trypanosoma cruzi. Biochem. Biophys. Res. Commun. 550, 722-733 (1979).
28. Taylor, M.C., Muhia, D.K., Baker, D.A., Mondragon, A., Schaap, P.B., and Kelly, J.M. Trypanosoma cruzi adenylyl cyclase is encoded by a complex multigene family. Mol. Biochem. Parasitol. 104, 205-217 (1999). Was the first description and characterization of the multi-gene family of adenylyl cyclases in T. cruzi.
29. Alexandre, S., Paindavoine, P., Hanocq-Quertier, J., Paturiaux-Hanocq, F., Tebabi, P., and Pays, E. Families of adenylate cyclase genes in Trypanosoma brucei. Mol. Biochem. Parasitol. 77, 173-182 (1996).
30. Alexandre, S., Paindavoine, P., Tebabi, P., Pays, A., Halleux, S., Steinert, M., and Pays, E. Differential expression of a family of putative adenylate/guanylate cyclase genes in Trypanosoma brucei. Mol. Biochem. Parasitol. 43, 279-288 (1990).
31. Paindavoine, P., Rolin, S., Van Assel, S., Geuskens, M., Jauniaux, J. C., Dinsart, C., Huet, G., and Pays, E. A gene from the variant surface glycoprotein expression site encodes one of several transmembrane adenylate cyclases located on the flagellum of Trypanosoma brucei. Mol. Cell. Biol. 12, 1218-1225 (1992).
32. Ross, D.T., Raibaud, A., Florent, I.C., Sather, S., Gross, M.K., Storm, D.R., and Eisen, H. The trypanosome VSG expression site encodes adenylate cyclase and a leucine-rich putative regulatory gene. EMBO J. 10, 2047-2053 (1991). References 31 and 32 describe the expression of trypanosomes adenylyl cyclase genes on the polycistronic transcription unit of the variant surface glycoprotein genes, and speculated a correlation between the adenylyl cyclase gene expression and VSG expression and trypanosome transformation.
33. Tang, W.J. and Gilman, A.G. Adenylyl cyclases. Cell 70, 869-872 (1992).
34. Bieger, B. and Essen, L.O. Structural analysis of adenylate cyclases from Trypanosoma brucei in their monomeric state. EMBO J. 20, 433-445 (2001). Was the first X-ray crystal structure of adenylyl cyclase genes from T. brucei and revealed subtle structural differences from mammalian adenylyl cyclases.
35. Naula, C., Schaub, R., Leech, V., Melville, S., and Seebeck, T. Spontaneous dimerization and leucine-zipper induced activation of the recombinant catalytic domain of a new adenylyl cyclase of Trypanosoma brucei, GRESAG4.4B. Mol. Biochem. Parasitol. 112, 19-28 (2001).
36. Berriman, M., Ghedin, E., Hertz-Fowler, C. et al. The genome of the African trypanosome Trypanosoma brucei. Science 309, 416-422 (2005).
37. El-Sayed, N.M., Myler, P.J., Bartholomeu, D.C. et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309, 409-415 (2005). References 36 and 37 reported the complete genome sequences of T. brucei and T. cruzi, providing an invaluable resource for trypanosome researchers.
38. Hoek, M., Engstler, M., and Cross, G.A. Expression-site-associated gene 8 (ESAG8) of Trypanosoma brucei is apparently essential and accumulates in the nucleolus. J. Cell Sci. 113(Pt 22), 3959-3968 (2000).
39. Hoek, M., Zanders, T., and Cross, G.A. Trypanosoma brucei expression-site-associated gene 8 protein interacts with a Pumilio family protein. Mol. Biochem. Parasitol. 120, 269-283 (2002).
40. Desaubry, L., Shoshani, I., and Johnson, R.A. Inhibition of adenylyl cyclase by a family of newly synthesized adenine nucleoside 3′- polyphosphates. J. Biol. Chem. 271, 14028-14034 (1996).
41. Martin, B.R., Voorheis, H.P., and Kennedy, E.L. Adenylate cyclase in bloodstream forms of Trypanosoma (Trypanozoon) brucei sp. Biochem. J. 175, 207-212 (1978).
42. Fraidenraich, D., Pena, C., Isola, E.L. et al. Stimulation of Trypanosoma cruzi adenylyl cyclase by an alpha D-globin fragment from Triatoma hindgut: Effect on differentiation of epimastigote to trypomastigote forms. Proc. Natl. Acad. Sci. U.S.A. 90, 10140-10144 (1993).
43. van den Abbeele, J., Rolin, S., Claes, Y., Le Ray, D., Pays, E., and Coosemans, M. Trypanosoma brucei: Stimulation of adenylate cyclase by proventriculus and esophagus tissue of the tsetse fly, Glossina morsitans morsitans. Exp. Parasitol. 81, 618-620 (1995).
44. D'Angelo, M.A., Montagna, A.E., Sanguineti, S., Torres, H.N., and Flawia, M.M. A novel calcium-stimulated adenylyl cyclase from Trypanosoma cruzi, which interacts with the structural flagellar protein paraflagellar rod. J. Biol. Chem. 277, 35025-35034 (2002).
45. Voorheis, H.P. and Martin, B.R. Characteristics of the calcium-mediated mechanism activating adenylate cyclase in Trypanosoma brucei. Eur. J. Biochem. 116, 471-477 (1981).
46. Voorheis, H.P. and Martin, B.R. Local anaesthetics including benzyl alcohol activate the adenylate cyclase in Trypanosoma brucei by a calcium-dependent mechanism. Eur. J. Biochem. 123, 371-376 (1982).
47. Pereira, N.M., Timm, S.L., da Costa, S.C., Rebello, M.A., and de Souza, W. Trypanosoma cruzi: Isolation and characterization of membrane and flagellar fractions. Exp. Parasitol. 46, 225-234 (1978).
48. Walter, R.D. 3′,5′-cyclic-AMP phosphodiesterase from Trypanosoma gambiense. Hoppe Seylers Z. Physiol. Chem. 355, 1443-1450 (1974).
49. Goncalves, M. F., Zingales, B., and Colli, W. cAMP phosphodiesterase and activator protein of mammalian cAMP phosphodiesterase from Trypanosoma cruzi. Mol. Biochem. Parasitol. 1, 107-118 (1980).
50. Kunz, S., Beavo, J.A., D'Angelo, M.A. et al. Cyclic nucleotide specific phosphodiesterases of the kinetoplastida: A unified nomenclature. Mol. Biochem. Parasitol. 145, 133-135 (2006). Describes and defines all the different PDE families in trypanosomes.
51. Rascon, A., Soderling, S.H., Schaefer, J.B., and Beavo, J.A. Cloning and characterization of a cAMP-specific phosphodiesterase (TbPDE2B) from Trypanosoma brucei. Proc. Natl. Acad. Sci. U.S.A. 99, 4714-4719 (2002). References 51 and 52 were the first to identify, clone, and characterize PDE enzymes in trypanosomes, and showed that these T. brucei PDEs were cAMP specific and highly insensitive to mammalian PDE inhibitors.
52. Zoraghi, R. and Seebeck, T. The cAMP-specific phosphodiesterase TbPDE2C is an essential enzyme in bloodstream form Trypanosoma brucei. Proc. Natl. Acad. Sci. U.S.A. 99, 4343-4348 (2002). This reference used RNAi to knock-down levels of the PDEB family (earlier called PDE2 family) in T. brucei, and showed that they were essential for the survival of proliferating, bloodstream forms of T. brucei.
53. Zoraghi, R., Kunz, S., Gong, K., and Seebeck, T. Characterization of TbPDE2A, a novel cyclic nucleotide-specific phosphodiesterase from the protozoan parasite Trypanosoma brucei. J. Biol. Chem. 276, 11559-11566 (2001).
54. D'Angelo, M.A., Sanguineti, S., Reece, J.M., Birnbaumer, L., Torres, H.N. and Flawia, M.M. Identification, characterization and subcellular localization of TcPDE1, a novel cAMP-specific phosphodiesterase from Trypanosoma cruzi. Biochem. J. 378, 63-72 (2004).
55. Diaz-Benjumea, R., Laxman, S., Hinds, T.R., Beavo, J.A., and Rascon, A. Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi. Biochem. J. 399, 305-314 (2006).
56. Kunz, S., Oberholzer, M. and Seebeck, T. A FYVE-containing unusual cyclic nucleotide phosphodiesterase from Trypanosoma cruzi. FEBS J. 272, 6412-6422 (2005).
57. Kunz, S., Kloeckner, T., Essen, L.O., Seebeck, T., and Boshart, M. TbPDE1, a novel class I phosphodiesterase of Trypanosoma brucei. Eur. J. Biochem. 271, 637-647 (2004).
58. Alonso, G.D., Schoijet, A.C., Torres, H.N., and Flawia, M.M. TcrPDEA1, a cAMP-specific phosphodiesterase with atypical pharmacological properties from Trypanosoma cruzi. Mol. Biochem. Parasitol. 152, 72-79 (2007).
59. Laxman, S., Rascon, A., and Beavo, J.A. Trypanosome cyclic nucleotide phosphodiesterase 2B binds cAMP through its GAF-A domain. J. Biol. Chem. 280, 3771-3779 (2005). This reference showed that the PDEB phosphodiesterase family from T. brucei selective bound cAMP in the GAF domain and appeared to be regulated by cAMP. Subsequently, other cAMP binding PDE GAF domains were described in T. cruzi and mammals.
60. Bender, A.T. and Beavo, J.A. Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacol. Rev. 58, 488-520 (2006).
61. Stenmark, H., Aasland, R., Toh, B.-H,. and Dagger, A.D. Endosomal localization of the autoantigen EEA1 is mediated by a zinc-binding FYVE finger. J. Biol. Chem. 271, 24048-24054 (1996).
62. Balla, T. Inositol-lipid binding motifs: Signal integrators through protein-lipid and protein-protein interactions. J. Cell Sci. 118, 2093-2104 (2005).
63. Oberholzer, M., Marti, G., Baresic, M., Kunz, S., Hemphill, A., and Seebeck, T. The Trypanosoma brucei cAMP phosphodiesterases TbrPDEB1 and TbrPDEB2: Flagellar enzymes that are essential for parasite virulence. FASEB J. 21, 720-731 (2006). In this study, in rodent models infected with T. brucei, PDEB levels were knocked-down in vivo using a drug-induced knock-down cell line of T. brucei, and this resulted in the elimination of the parasite from the rodent bloodstream, suggesting that this family of PDEs could indeed be potential drug targets in these parasites.
64. Shalaby, T., Liniger, M., and Seebeck, T. The regulatory subunit of a cGMP-regulated protein kinase A of Trypanosoma brucei. Eur. J. Biochem. 268, 6197-6206 (2001).
65. Ulloa, R.M., Mesri, E., Esteva, M., Torres, H.N., and Tellez-Inon, M.T. Cyclic AMP-dependent protein kinase activity in Trypanosoma cruzi. Biochem. J. 255, 319-326 (1988).
66. Ochatt, C.M., Ulloa, R.M., Torres, H.N., and Tellez-Inon, M.T. Characterization of the catalytic subunit of Trypanosoma cruzi cyclic AMP-dependent protein kinase. Mol. Biochem. Parasitol. 57, 73-81 (1993).
67. Huang, H., Werner, C., Weiss, L.M., Wittner, M., and Orr, G.A. Molecular cloning and expression of the catalytic subunit of protein kinase A from Trypanosoma cruzi. Int. J. Parasitol. 32, 1107-1115 (2002).
68. Banerjee, C. and Sarkar, D. Isolation and characterization of a cyclic nucleotide-independent protein kinase from Leishmania donovani. Mol. Biochem. Parasitol. 52, 195-205 (1992).
69. Siman-Tov, M.M., Aly, R., Shapira, M., and Jaffe, C.L. Cloning from Leishmania major of a developmentally regulated gene, c-lpk2, for the catalytic subunit of the cAMP-dependent protein kinase. Mol. Biochem. Parasitol. 77, 201-215 (1996).
70. Huang, H., Weiss, L.M., Nagajyothi, F., Tanowitz, H.B., Wittner, M., Orr, G.A., and Bao, Y. Molecular cloning and characterization of the protein kinase A regulatory subunit of Trypanosoma cruzi. Mol. Biochem. Parasitol. 149, 242-245 (2006). This study identifies and characterizes the bonafide cAMP regulated protein kinase A subunit. Earlier studies had suggested putative PKA catalytic domains but had not been able to identify a regulatory subunit that bound and responded to cAMP.
71. Ivens, A.C., Peacock, C.S., Worthey, E.A. et al. The genome of the kinetoplastid parasite, Leishmania major. Science 309, 436-442 (2005).
72. 2+-binding domain. J. Biol. Chem. 273, 15879-15882 (1998).
73. Carlisle, J.J. and Scott, J.D. AKAP mediated signal transduction. Annu. Rev. Pharmacol. Toxicol. 42, 235-257 (2002).
74. Parsons, M., Worthey, E.A., Ward, P.N., and Mottram, J.C. Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi. BMC Genomics 6, 127 (2005).
75. Docampo, R., de Souza, W., Miranda, K., Rohloff, P. and Moreno, S.N. Acidocalcisomes: Conserved from bacteria to man. Nat. Rev. Microbiol. 3, 251-261 (2005). This article describes the profile of all protein, carbohydrate, and lipid kinases expressed in the three trypanosomatids.
76. Montalvetti, A., Rohloff, P., and Docampo, R. A functional aquaporin colocalizes with the vacuolar proton pyrophosphatase to acidocalcisomes and the contractile vacuole complex of Trypanosoma cruzi. J. Biol. Chem. 279, 38673-38682 (2004).
77. Rohloff, P., Montalvetti, A., and Docampo, R. Acidocalcisomes and the contractile vacuole complex are involved in osmoregulation in Trypanosoma cruzi. J. Biol. Chem. 279, 52270-52281 (2004). This study describes the trypanosome aquaporin-acidocalcisome complex and suggests the regulation of the trafficking of this complex by cAMP, analogous to the mammalian aquaporin complex. The role or requirement for cAMP in these processes, however, needs to be definitively proven.
78. Valenti, G., Procino, G., Tamma, G., Carmosino, M., and Svelto, M. Aquaporin 2 trafficking. Endocrinology 146, 5063-5070 (2005).
79. Kohl, L. and Bastin, P. The flagellum of trypanosomes. Int. Rev. Cytol. 244, 227-285 (2005).
80. Vaughan, S. and Gull, K. The trypanosome flagellum. J. Cell Sci. 116, 757-759 (2003).
81. Oberholzer, M., Bregy, P., Marti, G., Minca, M., Peier, M., and Seebeck, T. Trypanosomes and mammalian sperm: One of a kind? Trends Parasitol. 23, 71-77 (2007).
82. Laxman, S., Riechers, A., Sadilek, M., Schwede, F., and Beavo, J.A. Hydrolysis products of cAMP analogs cause transformation of Trypanosoma brucei from slender to stumpy-like forms. Proc. Natl. Acad. Sci. U.S.A. 103, 19194-19199 (2006). These studies refuted the long held notion that cAMP directly caused the differentiation of slender bloodstream forms of T. brucei to non-proliferating stumpy forms, and also suggested the potential therapeutic use of specific adenosine analogs to prevent the proliferation T. brucei in the mammalian bloodstream.
83. Seed, J.R. and Wenck, M.A. Role of the long slender to short stumpy transition in the life cycle of the African trypanosomes. Kinetoplastid Biol. Dis. 2, 3 (2003).